| | Tubing enhances phaco
| | Enhanced low-compliance tubing on a proprietary phaco platform may help to increase vacuum limit safely and allow the surgeon to lower the bottle height or decrease the incision size with greater stability and safety without reduced ergonomic convenience. | |  |
|
|
| Sulcus placement of a proprietary three-piece multifocal IOL restores good outcome
| | Ophthalmology Times | | Sulcus placement of a proprietary three-piece multifocal IOL (ReZoom, Abbott Medical Optics) is a viable option in eyes in which capsular bag support is not adequate to ensure good lens stability. Then, if the lens decenters in the sulcus, scleral suturing is a safe and effective option for recentering the IOL and restoring good vision. |
| | | | Biaxial phaco with torsional ultrasound enhanced with tip and technique modifications
| Bevel-down orientation improves safety and efficiency, bend configuration increases thermal safety
| | Ophthalmology Times | | A new phaco tip (Fine OZil Tip, MicroSurgical Technology) for use with a proprietary handpiece (OZil, Alcon Laboratories) improves the safety and efficiency of phacoemulsification using torsional ultrasound with a biaxial microincisional technique. Modification of the phaco parameters improves chopping and segment removal. |
| | Dual-linear phacoemulsification platform separates phaco, vacuum
| Dual-linear system allows for lower mean power compared with single linear, results show
| | Ophthalmology Times | | A dual-linear phacoemulsification platform (available on the Stellaris, Bausch & Lomb) separates phaco and vacuum, allowing cataract surgeons to maximize their control over the cataract removal procedure. |
|
| World Sight Day set for Oct. 8
| | Ophthalmology Times E-News | | Three hundred events in more than 50 countries will mark this year's World Sight Day, Oct. 8. |
| | | AMO launches online ordering service
| | Ophthalmology Times E-News | | Abbott Medical Optics (AMO) has launched a new online ordering service (AMOeasy, www.amoeasy.com) whereby customers can order the company?s implants and other cataract-related products as well as track orders at any time of day. |
| | | ISTA to seek bromfenac label change
| | Ophthalmology Times E-News | | ISTA Pharmaceuticals plans to ask the FDA to approve a change to the label of its bromfenac 0.09% ophthalmic solution after obtaining positive preliminary phase III results in a confirmatory clinical study of once-daily bromfenac (Xibrom QD) for the treatment of inflammation and pain after cataract surgery. |
|
| 
Practice Tools
